EMEA-000368-PIP01-08 - paediatric investigation plan

travoprost
brinzolamide
PIPHuman

Key facts

Active substance
  • travoprost
  • brinzolamide
Therapeutic area
Ophthalmology
Decision number
P/130/2008
PIP number
EMEA-000368-PIP01-08
Pharmaceutical form(s)
Suspension
Condition(s) / indication(s)
  • Treatment of glaucoma
  • Treatment of ocular hypertension
Route(s) of administration
Eye drops
Contact for public enquiries

Alcon Laboratories (UK) Ltd.

Doug.MacHatton@AlconLabs.com
United States
Phone: +1 8175518974
Fax: +1 8176154607

Decision type
W: decision granting a waiver in all age groups for all conditions or indications
Decision date
Compliance check done
No

Decision

Share this page